After the event, a full recording of the interview will be available on the Company's X channel (@CardiolRx) and Barchart's (@Barchart). Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a ...
View Cardiol Therapeutics Inc. Class A CRDL stock quote prices, financial information, real-time forecasts, and company news from CNN.
Cardiol Therapeutics Inc (NASDAQ:CRDL) shares are trading lower by 18.4% to $1.60 Wednesday morning after the company announced a $13.5 million public offering of 8,437,500 common shares priced at ...
Oakville, Ontario--(Newsfile Corp. - October 11, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the ...
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic therapies for heart disease, today ...
Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and ...
Oakville, Ontario--(Newsfile Corp. - August 9, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing innovative ...
Leading enrolling centers include Cleveland Clinic, three major campuses of the Mayo Clinic, Northwestern University, Massachusetts General Hospital, Columbia University-NewYork-Presbyterian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results